Dealing With Anxiety: A Cognitive Behavioural Program for Diabetes

Sponsor
Hunter and New England Health (Other)
Overall Status
Completed
CT.gov ID
NCT00659932
Collaborator
(none)
64
1
2
34
1.9

Study Details

Study Description

Brief Summary

This study was designed to assess whether a cognitive behavior therapy (CBT) program for diabetes clinic patients was acceptable, improved quality of life and produced measurable change in levels of depression, anxiety and stress.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Immediate Cognitive behavioural therapy (CBT)
  • Behavioral: Delayed CBT
N/A

Detailed Description

Having co-morbid anxiety or depression makes it difficult to carry out the activities for diabetes selfcare. Psychological interventions have been shown to result in improvements in HbA1C and depression. Reports on psychosocial outcomes are conflicting and there are no studies of quality of life. Our diabetes outpatient population has a higher prevalence of anxiety and depression compared to the general public and this led to the development of a group CBT intervention designed to reduce anxiety as a co-morbidity of diabetes.

Study Design

Study Type:
Interventional
Actual Enrollment :
64 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Primary Purpose:
Treatment
Official Title:
Dealing With Anxiety: A Pilot Cognitive Behavioural Program for Diabetic Clinic Outpatient Attendees
Study Start Date :
May 1, 2002
Actual Primary Completion Date :
Mar 1, 2005
Actual Study Completion Date :
Mar 1, 2005

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Behavioral: Immediate Cognitive behavioural therapy (CBT)
The Dealing with Anxiety CBT Group Program comprises 7 group sessions: an initial five hour session followed by 6 three hour sessions over a three month period

Active Comparator: 2

Behavioral: Delayed CBT
Commencement of the CBT Group Program is delayed 3 months

Outcome Measures

Primary Outcome Measures

  1. Hemoglobin A1C (HbA1C) [6 months]

Secondary Outcome Measures

  1. Depression Anxiety Stress Scale (DASS) [6 months]

  2. Diabetes Quality of Life (ADDQoL) [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Consenting attendees of the Hunter Area Diabetes Services RNH Diabetes Outpatient Clinic
Exclusion Criteria:
  • Accessibility problems including:

  • limited English

  • developmental disability

  • physical immobility

  • geographical distance

  • extreme age/frailty

Contacts and Locations

Locations

Site City State Country Postal Code
1 Royal Newcastle Hospital Newcastle New South Wales Australia 2300

Sponsors and Collaborators

  • Hunter and New England Health

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00659932
Other Study ID Numbers:
  • 02/03/13/3.18
First Posted:
Apr 17, 2008
Last Update Posted:
Apr 17, 2008
Last Verified:
Dec 1, 2007
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 17, 2008